Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Myco-Rapha logo — Advancing healthcare with innovative vaccines and early TB d...

Myco-Rapha

Advancing healthcare with innovative vaccines and early TB detection solutions

Founded 2021 Pre-Seed Health Care

General Information

Company Name Myco-Rapha
Founded Year 2021
Industries Health Care
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Myco-Rapha. To contact Myco-Rapha, visit myco-rapha.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Myco-Rapha

With a focus on advancing healthcare through innovative vaccines and early TB detection solutions, Myco-Rapha has quickly made a name for itself in the Health Care industry since its founding in 2021. The company's commitment to research and development is evident in its work to develop vaccines and a field-applied TB diagnosis method for the early detection of TB patients. This dedication has garnered attention from investors, with the most recent Venture Round investment coming from ActnerLab on 01 January 2022. Myco-Rapha's innovative approach and potential to make a significant impact on healthcare make it a compelling prospect for venture capital investment.

Taxonomy: vaccine development, tuberculosis detection, medical research, diagnostic solutions, health innovation, R&D company, public health, disease prevention

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round Myco Undisclosed 1
ActnerLab
ActnerLab
01 Jan 2022

Myco-Rapha Alternatives & Competitors

Myco-Rapha vs
Tulane National Primate Research Center
Tulane National Primate Research Center United States

Tulane National Primate Research Center improves human and animal health through basic and applied b...

Grant
160 employees
Biotechnology, Health Care
Myco-Rapha vs
EMPE Diagnostics
EMPE Diagnostics Sweden

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care
Myco-Rapha vs
VaxInnate
VaxInnate

Advancing the future of healthcare with innovative vaccines for flu, malaria, dengue, papillomavirus...

Venture round
Biotechnology, Health Care

FAQ About Myco-Rapha

Advancing healthcare with innovative vaccines and early TB detection solutions
Myco-Rapha was founded in 2021.
Myco-Rapha operates in Health Care. Its work centres on vaccine development, tuberculosis detection, medical research and diagnostic solutions.
Myco-Rapha has completed 1 funding round. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Myco-Rapha include Tulane National Primate Research Center, EMPE Diagnostics, VaxInnate, ANCON Medical, Valneva. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Myco-Rapha and Tulane National Primate Research Center are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Myco-Rapha, https://bouncewatch.com/company/myco-rapha, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes